Your browser doesn't support javascript.
loading
Involvement of ANXA5 and ILKAP in susceptibility to malignant melanoma.
Arroyo-Berdugo, Yoana; Alonso, Santos; Ribas, Gloría; Ibarrola-Villava, Maider; Peña-Chilet, María; Martínez-Cadenas, Conrado; Gardeazabal, Jesús; Ratón-Nieto, Juan Antonio; Sánchez-Díez, Ana; Careaga, Jesús María; Pérez-Yarza, Gorka; Carretero, Gregorio; Martín-González, Manuel; Gómez-Fernández, Cristina; Nagore, Eduardo; Asumendi, Aintzane; Boyano, María Dolores.
Affiliation
  • Arroyo-Berdugo Y; Department of Cell Biology and Histology, School of Medicine and Dentistry, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain.
  • Alonso S; Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain.
  • Ribas G; Department of Hematology and Medical Oncology, Instituto Investigación Sanitaria, INCLIVA, Valencia, Spain.
  • Ibarrola-Villava M; Department of Hematology and Medical Oncology, Instituto Investigación Sanitaria, INCLIVA, Valencia, Spain.
  • Peña-Chilet M; Department of Hematology and Medical Oncology, Instituto Investigación Sanitaria, INCLIVA, Valencia, Spain.
  • Martínez-Cadenas C; Department of Medicine, University of Castellon Jaume I, Castellon, Spain.
  • Gardeazabal J; Department of Dermatology, Ophthalmology and Otorhinolaryngology, UPV/EHU, Service of Dermatology, BioCruces Health Research Institute, Cruces University Hospital, Barakaldo, Bizkaia, Spain.
  • Ratón-Nieto JA; Department of Dermatology, Ophthalmology and Otorhinolaryngology, UPV/EHU, Service of Dermatology, BioCruces Health Research Institute, Cruces University Hospital, Barakaldo, Bizkaia, Spain.
  • Sánchez-Díez A; Department of Dermatology, Ophthalmology and Otorhinolaryngology, UPV/EHU, Service of Dermatology, BioCruces Health Research Institute, Basurto University Hospital, Bilbao, Bizkaia, Spain.
  • Careaga JM; Department of Dermatology, Ophthalmology and Otorhinolaryngology, UPV/EHU, Service of Dermatology, BioCruces Health Research Institute, Basurto University Hospital, Bilbao, Bizkaia, Spain.
  • Pérez-Yarza G; Department of Cell Biology and Histology, School of Medicine and Dentistry, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain.
  • Carretero G; Department of Dermatology, Doctor Negrin Hospital, Las Palmas de Gran Canaria, Spain.
  • Martín-González M; Department of Dermatology, Ramón y Cajal Hospital, Madrid, Spain.
  • Gómez-Fernández C; Deparment of Dermatology, La Paz University Hospital, Madrid, Spain.
  • Nagore E; Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.
  • Asumendi A; Department of Cell Biology and Histology, School of Medicine and Dentistry, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain.
  • Boyano MD; Department of Cell Biology and Histology, School of Medicine and Dentistry, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain.
PLoS One ; 9(4): e95522, 2014.
Article in En | MEDLINE | ID: mdl-24743186

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Annexin A5 / Phosphoprotein Phosphatases / Melanoma Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2014 Document type: Article Affiliation country: Spain Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Annexin A5 / Phosphoprotein Phosphatases / Melanoma Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2014 Document type: Article Affiliation country: Spain Country of publication: United States